» Articles » PMID: 30486770

Genomic Insights into Virulence Mechanisms of Leishmania Donovani: Evidence from an Atypical Strain

Overview
Journal BMC Genomics
Publisher Biomed Central
Specialty Genetics
Date 2018 Nov 30
PMID 30486770
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Leishmaniasis is a neglected tropical disease with diverse clinical phenotypes, determined by parasite, host and vector interactions. Despite the advances in molecular biology and the availability of more Leishmania genome references in recent years, the association between parasite species and distinct clinical phenotypes remains poorly understood. We present a genomic comparison of an atypical variant of Leishmania donovani from a South Asian focus, where it mostly causes cutaneous form of leishmaniasis.

Results: Clinical isolates from six cutaneous leishmaniasis patients (CL-SL); 2 of whom were poor responders to antimony (CL-PR), and two visceral leishmaniasis patients (VL-SL) were sequenced on an Illumina MiSeq platform. Chromosome aneuploidy was observed in both groups but was more frequent in CL-SL. 248 genes differed by 2 fold or more in copy number among the two groups. Genes involved in amino acid use (LdBPK_271940) and energy metabolism (LdBPK_271950), predominated the VL-SL group with the same distribution pattern reflected in gene tandem arrays. Genes encoding amastins were present in higher copy numbers in VL-SL and CL-PR as well as being among predicted pseudogenes in CL-SL. Both chromosome and SNP profiles showed CL-SL and VL-SL to form two distinct groups. While expected heterozygosity was much higher in VL-SL, SNP allele frequency patterns did not suggest potential recent recombination breakpoints. The SNP/indel profile obtained using the more recently generated PacBio sequence did not vary markedly from that based on the standard LdBPK282A1 reference. Several genes previously associated with resistance to antimonials were observed in higher copy numbers in the analysis of CL-PR. H-locus amplification was seen in one cutaneous isolate which however did not belong to the CL-PR group.

Conclusions: The data presented suggests that intra species variations at chromosome and gene level are more likely to influence differences in tropism as well as response to treatment, and contributes to greater understanding of parasite molecular mechanisms underpinning these differences. These findings should be substantiated with a larger sample number and expression/functional studies.

Citing Articles

Evaluation of CD1a immunostaining in the diagnosis of cutaneous leishmaniasis caused by in Sri Lanka.

Riyal H, Samaranayake N, Amarathunga P, Munidasa D, Karunaweera N Parasitology. 2024; 151(10):1148-1153.

PMID: 39523649 PMC: 11894021. DOI: 10.1017/S0031182024000799.


Autochthonous Leishmaniasis Caused by Leishmania tropica, Identified by Using Whole-Genome Sequencing, Sri Lanka.

Silva H, Ferreira T, Muneeswaran K, Samarasinghe S, Alves-Ferreira E, Grigg M Emerg Infect Dis. 2024; 30(9):1872-1883.

PMID: 39174018 PMC: 11347009. DOI: 10.3201/eid3009.231238.


Risk Factor Analysis of Cutaneous Leishmaniasis in Sri Lanka through a Nationwide Survey.

Dewasurendra R, Samaranayake N, Silva H, Manamperi N, Senerath U, Senanayake S Am J Trop Med Hyg. 2024; 110(6):1110-1116.

PMID: 38593788 PMC: 11154038. DOI: 10.4269/ajtmh.23-0623.


Histological findings associated with treatment response in cutaneous leishmaniasis: a clinicopathological correlation study.

Riyal H, Samaranayake N, Amarathunga P, Munidasa D, Karunaweera N Int J Dermatol. 2023; 62(10):1237-1247.

PMID: 37723978 PMC: 10516507. DOI: 10.1111/ijd.16826.


First evidence of experimental genetic hybridization between cutaneous and visceral strains of Leishmania donovani within its natural vector Phlebotomus argentipes.

Riyal H, Ferreira T, Paun A, Ghosh K, Samaranayake N, Sacks D Acta Trop. 2023; 245:106979.

PMID: 37391025 PMC: 11332911. DOI: 10.1016/j.actatropica.2023.106979.


References
1.
Tovar J, Wilkinson S, Mottram J, Fairlamb A . Evidence that trypanothione reductase is an essential enzyme in Leishmania by targeted replacement of the tryA gene locus. Mol Microbiol. 1998; 29(2):653-60. DOI: 10.1046/j.1365-2958.1998.00968.x. View

2.
Haimeur A, Guimond C, Pilote S, Mukhopadhyay R, Rosen B, Poulin R . Elevated levels of polyamines and trypanothione resulting from overexpression of the ornithine decarboxylase gene in arsenite-resistant Leishmania. Mol Microbiol. 1999; 34(4):726-35. DOI: 10.1046/j.1365-2958.1999.01634.x. View

3.
Cunningham M, Beverley S . Pteridine salvage throughout the Leishmania infectious cycle: implications for antifolate chemotherapy. Mol Biochem Parasitol. 2001; 113(2):199-213. DOI: 10.1016/s0166-6851(01)00213-4. View

4.
Junghae M, Raynes J . Activation of p38 mitogen-activated protein kinase attenuates Leishmania donovani infection in macrophages. Infect Immun. 2002; 70(9):5026-35. PMC: 128247. DOI: 10.1128/IAI.70.9.5026-5035.2002. View

5.
Mukherjee A, Boisvert S, Lima do Monte-Neto R, Coelho A, Raymond F, Mukhopadhyay R . Telomeric gene deletion and intrachromosomal amplification in antimony-resistant Leishmania. Mol Microbiol. 2013; 88(1):189-202. DOI: 10.1111/mmi.12178. View